DexamethasoneVarious toxicities and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1904卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14113-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：181 / 181

相关论文

共 50 条

[41] Ifosfamide/talimogene laherparepvecVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1941 (1) : 218 - 218
[42] Alfacalcidol/burosumab/phosphatesVarious toxicities and off-label use: case report
Reactions Weekly, 2024, 2033 (1) : 15 - 15
[43] Dapsone/immunosuppressants/rituximabVarious toxicities and off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 161 - 161
[44] AntineoplasticsVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1931 (1) : 86 - 86
[45] AntineoplasticsVarious toxicities, off-label use and lack of efficay: case report
Reactions Weekly, 2024, 2037 (1) : 51 - 51
[46] AntiviralsVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 77 - 77
[47] Ciclosporin/methotrexate/prednisoloneVarious toxicities and off-label use: case report
Reactions Weekly, 2019, 1769 (1) : 119 - 119
[48] DaptomycinVarious toxicities following overdose and off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 163 - 163
[49] PrednisoneVarious toxicities following misuse and off-label use: case report
Reactions Weekly, 2022, 1899 (1) : 329 - 329
[50] Buprenorphine/methadone/naloxoneVarious toxicities and off-label use: case report
Reactions Weekly, 2021, 1869 (1) : 82 - 82

← 1 2 3 4 5 →